2844
M. I. Burguete et al. / Tetrahedron 58 22002) 2839±2846
4.2.7. N,N0,N00,N000-Tetrakis o-nitrobenzenesulfonyl)-1,4,
7,10-tetraazadecane 10a). 53%. 1H NMR 1200 MHz,
DMSO-d6): 3.35 1m, 4H), 3.5±3.6 1m, 8H), 5.75 1t, 2H),
7.6±7.9 1m, 12H), 8.0±8.15 1m, 4H). 13C NMR: 42.4,
47.8, 49.0, 124.4, 124.8, 125.4, 131.0, 131.1, 131.6, 132.4,
132.5, 132.6, 132.9, 133.1, 133.9, 134.2, 135.9, 147.8,
147.9. Anal. Calcd for C30H30N8S4O16: C, 40.6; H, 3.4; N,
12.6; S, 14.5. Found: C, 41.0; H, 3.6; N, 12.5; S, 14.4.
1200 MHz, DMSO-d6): 1.3 1m, 4H), 1.9 1m, 4H), 2.8 1m,
4H), 4.4 1m, 2H), 5.1 1m, 2H), 7.4 1s, 2H), 7.7 1m, 2H), 8.0±
8.6 1m, 14H). 13C NMR: 27.1, 42.6, 42.9, 50.5, 124.0, 124.3,
124.5, 126.2, 127.1, 131.9, 146.0, 150.2. Anal. Calcd for
C36H34N6S3O12: C, 51.5; H, 4.1; N, 10.0; S, 11.5. Found:
C, 51.3; H, 4.3; N, 9.8; S, 11.7.
4.3.5. N,N0,N0,N000-Tetrakis p-nitrobenzenesulfonyl)-2,5,
8,11-tetraaza[12] 1,4)naphthalenophane 16b). 88%. H
1
4.2.8. N,N0,N00,N000-Tetrakis p-nitrobenzenesulfonyl)-1,4,
7,10-tetraazadecane 10). 62%. 1H NMR 1200 MHz,
DMSO-d6): 2.93 1m, 4H), 3.1±3.5 1m, 8H), 7.9±8.5 1m,
16H). 13C NMR: 45.6, 47.6, 48.6, 123.3, 124.6, 125.0,
127.0, 128.1, 128.6, 129.7, 149.6, 150.0. Anal. Calcd for
C30H30N8S4O16: C, 40.6; H, 3.4; N, 12.6; S, 14.5. Found:
C, 40.4; H, 3.5; N, 12.7; S, 14.4.
NMR 1200 MHz, DMSO-d6): 1.8 1m, 4H), 2.4 1m
broad, 6H), 3.1 1m, 2H), 4.0 1s broad, 2H), 5.4 1s
broad, 2H), 7.27 1s, 2H), 7.64 1m, 2H), 7.85±8.3 1m
broad, 16H), 8.4 1m, 2H). 13C NMR: 44.1, 45.3, 45.6,
50.7, 124.2, 124.6, 128.3, 130.3, 131.3, 132.0, 132.3,
134.3, 147.9, 148.3. Anal. Calcd for C42H38N8S4O16: C,
48.5; H, 3.7; N, 10.8; S, 12.3. Found: C, 48.3; H, 3.6; N,
10.7; S, 12.2.
4.3. General procedure for the preparation of
pernosylated cyclophanes
4.3.6.
N,N0,N00-Tris p-nitrobenzenesulfonyl)-2,5,8-tri-
aza[9] 9,10)anthracenophane 18b). 75%. 1H NMR
1200 MHz, DMSO-d6): 3.1 1m, 4H), 3.6 1m, 4H), 5.4 1s,
4H), 7.3±8.5 1m, 20H). 13C NMR: 45.3, 45.9, 51.8, 123.3,
124.7, 125.6, 126.9, 127.8, 129.1, 134.5, 148.3, 151.5. Anal.
Calcd for C38H32N6S3O12: C, 53.0; H, 3.8; N, 9.8; S, 11.2.
Found: C, 52.8; H, 3.9; N, 9.7; S, 11.3.
4.3.1. N,N0,N00,N000-Tetrakis p-nitrobenzenesulfonyl)-2,6,
9,13-tetraaza[14] 1,4)naphthalenophane 17b). Perno-
sylated polyamine 7 13 g, 3.2 mmol) and K2CO3 14.5 g,
32 mmol) were suspended in re¯uxing acetonitrile
1250 mL). To this mixture, a solution of 1,4-bis1bromo-
methyl)naphthalene 18) 11 g, 3.2 mmol) was added drop-
wise. After the addition was complete, the suspension was
re¯uxed for 72 h and then ®ltered. The solution was vacuum
evaporated to dryness to give the crude product as a yellow-
ish solid which was puri®ed by column chromatography on
4.3.7. N,N0,N00-Tris p-nitrobenzenesulfonyl)-2,6,10-tri-
aza[11] 9,10)anthracenophane 19b). 84%. 1H NMR
1200 MHz, DMSO-d6): 0.85 1m, 4H), 1.7 1m, 4H), 2.9 1m,
4H), 5.25 1s, 4H), 7.5 1m, 2H), 7.7 1m, 4H), 8.0±8.6 1m,
14H). 13C NMR: 29.7, 45.1, 45.8, 52.0, 124.6, 125.0, 125.6,
126.7, 128.0, 128.9, 129.5, 130.4, 131.4, 132.3, 133.6,
142.8, 144.0, 149.9. Anal. Calcd for C40H36N6S3O12: C,
54.1; H, 4.1; N, 9.4; S, 10.8. Found: C, 54.3; H, 4.0; N,
9.6; S, 10.6.
1
silica gel 1CH2Cl2/acetone, 9:1). 13.4 g, 90%). H NMR
1200 MHz, DMSO-d6): 1.25 1m, 4H, ±CH2±CH2±CH2±),
2.5±3.2 1m, 12H, CH2±N), 4.8 1s broad, 4H, Ar±CH2±N),
7.5 1s, 2H, Ar±H), 7.9 1d, 4H, Ar±H), 8.0±8.5 1m, 12 H,
Ar±H). 13C NMR: 28.5, 46.4, 46.7, 47.0, 53.2, 124.3, 124.7,
127.5, 128.0, 130.8, 131.1, 131.2, 131.8, 132.0, 132.2,
132.4, 132.6, 134.0, 134.2, 147.7, 148.6. IR: 3106, 1701,
1598, 1530, 1350, 1159, 853, 739. Anal. Calcd for
C44H42N8S4O16: C, 49.5; H, 4.0; N, 10.5; S, 12.0. Found:
C, 49.8; H, 3.8; N, 10.3; S, 12.2.
4.3.8. N,N0,N00,N000-Tetrakis p-nitrobenzenesulfonyl)-2,5,
8,11-tetraaza[12] 9,10)anthracenophane 20b). 80%. H
1
NMR 1200 MHz, DMSO-d6): 2.6±3.1 1m, 12H), 5.4 1s
broad), 4H), 7.3±7.8 1m, 8H), 7.9±8.7 1m, 16H). 13C
NMR: 45.3 1broad), 46.0, 47.6, 51.1, 124.7 1broad), 126.9,
127.8, 129.0, 129.9, 130.5, 142.4, 143.5, 149.9. Anal. Calcd
for C46H40N8S4O16: C, 50.7; H, 3.7; N, 10.3; S, 11.8. Found:
C, 50.6; H, 3.8; N, 10.1; S, 11.9.
4.3.2. N,N0,N00,N000-Tetrakis o-nitrobenzenesulfonyl)-2,6,
9,13-tetraaza[14] 1,4)naphthalenophane 17a). 98%. H
1
NMR 1200 MHz, DMSO-d6): 1.2 1m, 4H), 2.9±3.3 1m,
8H), 3.5 1s, 4H), 4.9 1s broad), 4H), 7.7 1s, 2H), 7.7±8.2
1m, 14H), 8.45 1m, 2H). 13C NMR: 27.8, 44.7, 45.2, 46.0,
52.3, 124.5, 124.6, 129.8, 131.0, 132.6, 134.7, 135.0, 147.9,
148.1. Anal. Calcd for C44H42N8S4O16: C, 49.5; H, 4.0; N,
10.5; S, 12.0. Found: C, 49.6; H, 3.9; N, 10.3; S, 12.2.
4.3.9. N,N0,N00,N000-Tetrakis p-nitrobenzenesulfonyl)-2,6,
9,13-tetraaza[14] 9,10)anthracenophane 21b). 87%. H
1
NMR 1200 MHz, DMSO-d6): 0.8 1m, 4H), 1.23 1s, 4H),
2.7 1m, 4H), 3.0 1m, 4H), 5.3 1s, 4H), 7.6 1m, 4H), 7.85
1d, 4H, J9.3 Hz), 8.2±8.4 1m, 8H), 8.6 1d, 4H,
J8.1 Hz), 8.7 1m, 4H). 13C NMR: 29.7, 45.1, 46.2, 46.4,
56.0, 124.8, 125.1, 125.6, 125.9, 126.8, 128.0, 128.4, 129.5,
130.8, 142.3, 143.9, 150.0, 150.4. Anal. Calcd for
C48H44N8S4O16: C, 51.6; H, 4.0; N, 10.0; S, 11.5. Found:
C, 51.5; H, 4.1; N, 10.1; S, 11.4.
4.3.3. N,N0,N00-Tris p-nitrobenzenesulfonyl)-2,5,8-triaza-
[9] 1,4)naphthalenophane
14b). 92%. 1H NMR
1200 MHz, DMSO-d6): 1.45 1m, 2H), 2.6±3.0 1m, 6H),
4.45 1d, 2H, J13.5 Hz), 5.54 1d, 2H, J13.5 Hz), 7.48
1m, 2H), 7.5±7.8 1m, 12H), 8.0 1m, 2H), 8.25 1dd, 2H,
J1 3.4 Hz, J26.5 Hz). 13C NMR: 44.8, 49.4, 51.8,
124.0, 124.2, 124.5, 128.1, 130.3, 131.0, 131.3, 132.0,
132.3, 132.6, 134.1, 147.8, 148.2. Anal. Calcd for
C34H30N6S3O12: C, 50.4; H, 3.7; N, 10.4; S, 11.9. Found:
C, 50.7; H, 3.8; N, 10.6; S, 11.8.
4.3.10. One-pot synthesis of naphthalenophanes and
anthracenophanes: 2,6,9,13-tetraaza[14] 9,10)anthra-
cenophane 29). A solution of 9,10-bis1bromomethyl)-
anthracene 113) 11.4 g, 3.8 mmol) in DMF1100 mL) was
added dropwise to a mixture of N,N0,N00,N000-tetrakis1o-nitro-
benzenesulfonyl)-1,5,8,12-tetraazadodecane 111a) 13.5 g,
3.8 mmol) and anhydrous K2CO3 15.2 g, 38 mmol) in dry
4.3.4. N,N0,N00-Tris p-nitrobenzenesulfonyl)-2,6,10-triaza-
[11]- 1,4)naphthalenophane 15b). 46%. 1H NMR